HELUS Pharma: Transitioning From Psychedelic Research To Late-Stage Clinical Neuroscience

HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus ...

The best products to cool down during hot flashes, according to menopause experts

Shop the best skin care, red light therapy and more to help treat hot flashes due to menopause. Shop products to help with ...

Gene therapy is transforming lives, but for many Americans it's hard to reach

Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...

Option Care Health outlines $5.8B–$6B 2026 revenue guidance while expanding infusion clinic network

Q4 2025 earnings call: 2026 guidance, revenue/EBITDA outlook, payer & tech strategy, and Stelara biosimilar headwinds—read now.

VetStem Cell Therapy Helps Dog Recover from Two Cruciate Ligament Tears

Mr. Pickles, a boxer, received VetStem Cell Therapy in conjunction with surgery for torn cruciate ligaments. This ...

PM Insights and IPO Prophet Partner to Deliver End-to-End Analytics from Private Markets to IPO Price Discovery

Data integration between IPO Prophet and PM Insights brings pre-IPO valuations and Day-1 trading intelligence together ...

NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Hologenix Expands Its DTC Offerings With New Bedding Products

CELLIANT's Celestial Sheets Launch This Month Using Infrared To Improve Sleep LOS ANGELES, CA / ACCESS Newswire / ...
PharmiWeb

Jaguar Gene Therapy Announces Successful Completion of Dosing of First Patient Cohort in Clinical Trial Evaluating JAG201 for the Treatment of a Leading Monogenic Cause of ...

Dosing of Cohort 1 complete with first three patients having received starting dose of JAG201 delivered via intracerebroventricular (ICV) injectionFirst two patients in dose-escalation Cohort 2 have ...